Enzastaurin in the treatment of recurrent glioblastoma: a promise that did not materialize.
Galanis
Evanthia
E
Buckner
Jan C
JC
D001932:Brain Neoplasms / Q000188:drug therapy*; D017326:Clinical Trials, Phase III as Topic; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*; D064546:Protein Kinase C beta; D012008:Recurrence; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000502:physiology
D007211:Indoles; D040301:Vascular Endothelial Growth Factor Receptor-2; D011493:Protein Kinase C; D064546:Protein Kinase C beta; C504878:enzastaurin